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Interaction between Rf-1 and Rf-4 quantitative trait loci in-
creases susceptibility to renal damage in double congenic rats.
Background. Five quantitative trait loci (QTLs), Rf-1 to Rf-
5, were found in Fawn-Hooded hypertensive (FHH) rats in-
fluencing susceptibility to renal damage. Previously, we found
that single transfer of the Rf-1 QTL from FHH rats onto the
renal-resistant August × Copenhagen Irish (ACI) strain caused
a small increase in renal susceptibility. To investigate the sep-
arate role of the Rf-4 QTL and its interaction with Rf-1, we
generated a single congenic strain carrying Rf-4 and a double
congenic carrying both Rf-1 and Rf-4.
Methods. Differences in renal susceptibility between ACI,
Rf-1A, and Rf-4 single congenics and Rf-1A+4 double con-
genics were assessed using four different treatments: control
(two-kidney), two-kidney with L-arginine analogue N-nitro-L-
arginine methyl ester (L-NAME)–induced hypertension, uni-
lateral nephrectomy, and unilateral nephrectomy + L-NAME.
In separate experiments, renal blood flow (RBF) autoregulation
was compared between two-kidney ACI and congenic rats.
Results. Compared to ACI, Rf-1A rats developed more renal
damage, while Rf-4 rats did not. The most severe renal dam-
age was found in the Rf-1A+4 double congenic rats. Analysis
of variance (ANOVA) demonstrated a significant interaction
between the Rf-1A and Rf-4 QTLs. The magnitude of the inter-
action varied with the type and duration of the treatment. The
RBF autoregulation was impaired in Rf-1A single and Rf-1A+4
double congenics, while in Rf-4 single congenics it was similar
to that of ACI controls.
Conclusion. These findings indicate that the Rf-1 QTL di-
rectly influences renal susceptibility and autoregulation. In con-
trast, the Rf-4 QTL shows no direct effects, but significantly
increases susceptibility to renal damage via an interaction with
Rf-1.
Chronic kidney disease is assumed to be a complex
polygenic disease [1–5]. Chromosomal loci, as well as
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specific genes, have been identified in various inherited
forms of renal disease [6, 7]. However, finding the genes
involved in the more complex forms of human end-
stage renal failure (ESRF) has been more arduous. Link-
age analysis has identified some chromosomal regions
possibly involved in diabetic and nondiabetic forms of
nephropathy, while candidate gene analyses have tested
several genes with limited success [4, 8, 9]. Studies in in-
bred rat strains might help to decrease the number of
candidate genes, which could facilitate finding genes in
human studies.
Inbred rat strains also vary widely in their susceptibility
to develop renal damage. Our studies involve the Fawn-
Hooded hypertensive (FHH) rat, prone to develop mild
systolic hypertension and marked proteinuria (UPV),
albuminuria (UAV), and focal and segmental glomeru-
losclerosis (FSGS) at relatively young age. Male FHH
rats die of ESRF within a year and a half if not treated.
[10, 11] The FHH strain is well characterized by numer-
ous physiologic and histologic studies [12–19]. Crosses
between FHH and the proteinuria-resistant August ×
Copehnagen Irish (ACI) rat revealed the presence of five
quantitative trait loci (QTLs) linked to UPV and other
parameters of renal damage. These QTLs were named
Renal failure-1 (Rf-1) to Rf-5 [20, 21]. It is surmised that
each of these QTLs contains gene(s) that play a role in
the development of progressive renal damage in the FHH
rat.
Even though the nature of the genes have not yet
been identified, the separate role of each QTL in the
initiation and progression of renal damage can be stud-
ied in congenic rat strains that have a Rf region of the
FHH rat introgressed into the genomic background of the
proteinuria-resistant ACI rat. Next, interactions between
the QTLs can be studied in double and multiple con-
genic strains. Previously, we reported about the suscep-
tibility to renal damage in ACI.FHH-Rf-1B (Rf-1B) and
ACI.FHH-Rf-5 (Rf-5) single congenic rats [22, 23]. Since
the ACI rat is resistant to renal damage even when made
hypertensive, we need to stress the kidney to initiate the
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renal failure phenotype and be able to study the effect
of a single QTL in the ACI background. The Rf-1B con-
genic rats developed significantly more UPV and UAV
than the ACI progenitor strain. This difference was most
pronounced following unilateral nephrectomy combined
with L-arginine analogue N-nitro-L-arginine methyl ester
(L-NAME)–induced hypertension.
In Rf-1B congenic rats, renal autoregulation was im-
paired to the same extent as the parental FHH rat [18].
In the FHH rat, the impaired renal autoregulation, re-
sulting in an elevated intraglomerular pressure (PGC) is
thought to be an important mechanism in the early de-
velopment of renal damage [13, 15, 19]. In contrast to
the Rf-1B congenic rats, the Rf-5 single congenic strain
showed no increase in renal susceptibility and a normal
renal blood flow (RBF) autoregulation [23]. In the Rf-1B
congenic, the levels of UPV and UAV following unilat-
eral nephrectomy and L-NAME treatment were much
less than those found in FHH [14]. This indicates that the
Rf-1 QTL only accounts for part of the renal damage in
FHH rats. Our previous linkage analysis suggested com-
plex interactions between the QTLs. With the exception
of Rf-1, the other Rf-QTLs by themselves showed lit-
tle effect on UPV. However, a marked increase in UPV
level was noted when these QTLs were combined with
Rf-1 [21]. Direct evidence for such an interaction can be
obtained by studying double congenic rats. Interactions
between blood pressure QTLs in rats have been described
previously [24, 25].
In the present experiments we wanted to test the
presence of an interaction between the Rf-1 and Rf-4
QTLs, as predicted from the linkage analysis [21]. There-
fore, we compared the renal susceptibility between the
ACI progenitor strain and three congenic strains (i.e.,
ACI.FHH-Rf1A, ACI.FHH-Rf-4 single congenics, and
ACI.FHH-Rf1+4 double congenics). We tested the hy-
pothesis that a gene-gene interaction occurs between the
Rf-1 and Rf-4 QTLs increasing the susceptibility to renal
damage.
METHODS
Congenic and control rat strains
For the experiments, single congenics ACI.FHH-
(D1Rat74-D1Rat90) (Rf-1A), ACI.FHH-(D14Mit11-
D14Rat82) (Rf-4), double congenic ACI.FHH-
(D1Mit18-D1Rat90)/(D14Mit11-D14Rat33/D14Rat65-
D14Rat90) (Rf-1A+4) rats, and ACI control rats were
used. All breeding was performed at the Animal
Research Center at Erasmus MC, Rotterdam, The
Netherlands. Animals were housed in individually
ventilated cages under specific pathogen free (SPF)
conditions as previously described [23, 26]. The protocol
received approval from the Animal Ethical Committee
of Erasmus MC.
Congenic rat strains were generated using a speed
congenic strategy as previously described for the Rf-1B
strain by Provoost et al [22]. A schematic view of the in-
trogressed Rf regions of the various congenic strains is
presented in Figure 1. The congenics generated here con-
tain the earlier reported 95% CI for Rf-1 and Rf-4. In
the Rf-1A single congenic strain, the congenic region is
on chromosome 1 between markers D1Rat74 (227.2 Mb)
and D1Rat90 (267.3 Mb), spanning 40.1 Mb, about 15%
of the chromosome. The Rf-1A region is about 17 Mb
larger than the region in the Rf-1B strain [22].
In the Rf-4 single congenic strain, the region is on chro-
mosome 14 between markers D14Mit11 (5.0 Mb) and
D14Rat82 (30.3 Mb), spanning 25.3 Mb, about 23% of
the chromosome. In the Rf-1A+4 double congenic rat
the Rf-1 congenic region is between D1Mit18 (224.6 Mb)
and D1Rat90 (267.3 Mb), spanning 42.7 Mb. In the Rf-
1A+4 double congenic rat the Rf-4 region is between the
markers D14Mit11 (5.0 Mb) and D14Rat33 (29.3 Mb),
spanning 24.3 Mb (i.e., 1.0 Mb smaller than in the Rf-4
single congenic). In addition, a second region of chro-
mosome 14 from FHH has been introgressed between
markers D14Rat65 (36.4 Mb) and D14Rat90 (74.0 Mb),
spanning 37.6 Mb. This region, however, is way outside
the 95% CI for the Rf-4 QTL (between 5 and 20 Mb) on
chromosome 14. A whole genome scan with 140 to 150
genetic markers on these three congenic strains showed
that there was no detected FHH genomic contamination
on other chromosomes.
Renal damage susceptibility
Experiments for assessment of renal damage suscepti-
bility were performed on 164 animals starting from the
age of 6 to 7 weeks. Per strain, the animals were randomly
divided over four treatment groups (Table 1). The first
received no treatment, remaining with two kidneys (i.e.,
control situation). The second remained with two kid-
neys and was chronically treated with L-NAME (Sigma-
Aldrich Chemicals, Zwijndrecht, The Netherlands) (two
kidneys + L-NAME) to induce systemic hypertension.
The third treatment consisted of renal mass reduction
by unilateral nephrectomy, and the fourth of unilateral
nephrectomy + L-NAME–induced hypertension.
Surgery for unilateral nephrectomy and L-NAME
treatment were performed as previously described [27].
There was some variation in the amount of L-NAME
intake. However, Figure 3 shows that blood pressure lev-
els were equivalent among the different strains of rats
within the different treatment groups. Urine of individual
rats was collected after 6, 12, and 18 weeks of treatment.
The animals were housed in metabolic cages (Tecniplast,
Buggugiate, Italy). Urine was collected during 2 consec-
utive days after a 3-day adaptation period. Following the
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Fig. 1. Genetic maps of rat chromosomes 1 and 14 depicting the homozygous Fawn-Hooded hypertensive (FHH) regions introgressed on the
August × Copenhagen Irish (ACI) background in the Rf-1A, Rf-4, and Rf-1A+4 congenic strains. The areas homozygous FHH in the congenic
strains are indicated by the solid and striped lines. The arrows indicate the locations of the Rf-1 and Rf-4 QTL peaks found in previous studies (i.e.,
D1Mgh12 for Rf-1 and D14Mgh7 for Rf-4 [34, 47]). Distances are given in megabase pairs (Mb). 95% CI represents the 95% confidence interval
of the quantitative trait loci (QTLs).
urine collection, systolic blood pressure was measured by
the tail-cuff method, using a photoelectric oscillatory de-
tection device (IITC Life Science, Woodland Hills, CA,
USA) in awake, restrained, but trained rats, as described
previously [22].
Shortly after the last series of urine collections and
systolic blood pressure measurements the animals were
sacrificed as previously described [23]. Kidneys were col-
lected and weighed. The left kidney was used for histo-
logic examination. The extent of glomerular damage was
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Table 1. Number of rats studied in the renal susceptibility experiments
Two-kidney Two kidney + L-NAME Unilateral nephrectomy Unilateral nephrectomy + L-NAME
August × Copenhagen Irish 6 6 10 9
Rf-1A 11 12 12 12
Rf-4 9 9 10 10
Rf-1A+4 12 10 12 14, 14, 10a
L-NAME is L-arginine analogue N-nitro-L-arginine methyl ester.
aNumber of rats at first, second, and third follow-up, respectively.
determined in 1 lm sections stained with periodic acid-
Schiff (PAS) reagent. In each animal, 50 glomeruli of the
left kidney were examined for the presence of sclerotic le-
sions (i.e., segmental glomerular scarring, obliteration of
glomerular capillaries, mesangial matrix expansion, and
adhesion formation between tuft and Bowman’s capsule).
The extent of glomerular damage was expressed as the
percentage of the glomeruli (% FSGS) showed one or
more of these features [23].
RBF autoregulation
Experiments for assessment of renal blood flow au-
toregulation were performed on 54 animals (15 ACI, 12
Rf-1A, 15 Rf-4, and 12 Rf-1A+4 rats) with an age of 13
to 15 weeks. To get an indication of the presence of renal
damage, UPV and UAV were assessed using a 24-hour
sample obtained before the autoregulation experiments,
while at the end of the evaluation both kidneys were col-
lected and weighed and the left kidney was used to de-
termine the%FSGS, as previously described [23].
Animals were anaesthetized with a mixture of 3%
Isoflurane, 30% N2O, and 60% O2 and surgically pre-
pared for autoregulation studies [18, 19]. After surgery
and a 10-minute equilibration period, the relationship be-
tween the left kidney RBF and the renal perfusion pres-
sure (RPP) was determined. The RBF was recorded as
the RPP was lowered from 150 to 80 mm Hg in 10 mm Hg
steps by tightening a clamp around the aorta, followed by
a 3-minute equilibration period. To normalize the out-
come of the individual rats, the RBF at a RPP of 100 mm
Hg (RBF100) was considered to be 100%. Renal autoreg-
ulatory indexes (RAIs) over the range of pressures from
80 to 150 mm Hg were calculated by the method of
Semple and de Wardener [28]. A RAI of 0 indicates per-
fect autoregulation of RBF, and a RAI of 1 indicates that
there is no autoregulation present due to a fixed renal
vascular resistance.
Analytic procedures
Plasma and urinary samples were analyzed with an
ELAN System (Eppendorf-Merck, Hamburg, Germany)
using colorimetric assays. Total urinary protein was de-
termined colorimetrically with pyrogallol red-molybdate
complex [29]. Plasma and urinary albumin levels were
determined with bromocresol green [30]. Plasma and uri-
nary creatinine levels were determined with the Jaffe´
method without deproteinization [31].
Statistics
Data are presented as mean ± SEM, unless stated oth-
erwise. Statistical differences in mean values between
groups were compared using one-way analysis of variance
(ANOVA), followed by the Bonferroni test to determine
which pairs were significantly different. These tests were
performed using the Primer of Biostatistics for Windows
program (version 4.0) (McGraw Hill, 1996).
For different parameters (X) the magnitude of the ef-
fects of the presence of the Rf-1 or Rf-4 QTL on the
ACI background and their interaction was calculated as
follows:
Effect of Rf-1 equals XRf−1A − XACI, effect of Rf-4
QTL equals XRf−4 − XACI, and the interaction between
the Rf-1 and Rf-4 QTLs equals XACI + XRf1+4 − XRf−1 −
XRf−4. In these formulas Xstrain is the mean value of the
parameter under investigation at the different time points
for the various strains and treatments. The standard de-
viation (SD) was calculated as the weighed SD of the
variables in the formulas.
Statistical significance of the main effect of the Rf-1
and Rf-4 QTLs and their interaction was calculated us-
ing a 2 × 2 factorial ANOVA procedure provided by
VassarStats (faculty.vassar.edu/lowry/anova2 × 2.html).
In all tests, a P value <0.05 was considered to be sta-
tistically significant.
RESULTS
Animal survival and albuminuria
All two-kidney, two-kidney + L-NAME, and unilat-
eral nephrectomy rats survived the 18-week follow-up
period. Following unilateral nephrectomy + L-NAME
treatment, four of the 14 Rf-1A+4 double congenic rats
did not survive up to the third measurement. Data ob-
tained from these four rats are included in the results for
the first and second measurements.
Both UPV and UAV values were assessed, and no re-
markable differences were found between the two values.
Mean values for UAV during follow-up from the various
treatments are presented in Figure 2. In the two-kidney
situation, UAV was significantly higher in Rf-1A+4
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Fig. 2. Albuminuria (UAV) after 6, 12, and 18 weeks of follow-up during four treatments on August × Copenhagen Irish (ACI) (), Rf-1A (),
Rf-4 (), and Rf-1A+4 (•) rats. (A) Two-kidney. (B) Two-kidney + L-arginine analogue N-nitro-L-arginine methyl ester (L-NAME)–induced
hypertension. (C) Unilateral nephrectomy. (D) Unilateral nephrectomy + L-NAME–induced hypertension. Values (mg/day per 100 g body weight)
are given as mean ± SEM, number of rats is given in Table 1. ∗P < 0.05 vs. ACI, Rf-1A, and Rf-4; ◦P < 0.05 vs. ACI and Rf-4; +P < 0.05 vs. Rf-4.
double congenic rats compared to Rf-4 single congen-
ics at all time points, to ACI at the second and third time
point, and to Rf-1A single congenic rats at the second
time point (Fig. 2A). Following two-kidney + L-NAME
treatment, UAV in Rf-1A+4 double congenic rats was sig-
nificantly increased at all time points compared to ACI,
Rf-4 and Rf-1A single congenic rats (Fig. 2B). Follow-
ing unilateral nephrectomy, UAV was at all time points
significantly higher in Rf-1A+4 double congenics com-
pared to ACI, or Rf-4 and Rf-1A single congenic rats.
The level of UAV in Rf-1A single congenic rats was sig-
nificantly higher compared to Rf-4 single congenics at
all time points and to ACI rats at the third time point
(Fig. 2C). When treated with unilateral nephrectomy +
L-NAME, UAV in Rf-1A+4 double congenic rats at all
time points was significantly increased compared to ACI,
Rf-4 and Rf-1A single congenic rats. In Rf-1A single con-
genics rats this treatment led, at the second and third
evaluation, to a significantly increased UAV compared
to ACI and Rf-4 single congenic rats (Fig. 2D). Regard-
less of treatment or time point, no statistically significant
differences in UAV were found in the Rf-4 single congenic
rats when compared to ACI (Fig. 2).
Systolic blood pressure
Values for systolic blood pressure are presented in
Figure 3. In the two-kidney situation, Rf-1A single con-
genic rats compared to ACI showed a small, but signif-
icant increase in systolic blood pressure at the first and
second evaluations (Fig. 3A). After unilateral nephrec-
tomy, a slightly higher systolic blood pressure was present
in the Rf-4 single congenics compared to ACI at the sec-
ond time point (Fig. 3C). Chronic L-NAME treatment
increased systolic blood pressure in all strains. At the sec-
ond and third evaluations, stylolic blood pressure in Rf-
1A+4 double congenic rats with two-kidney + L-NAME
treatment was significantly increased compared to ACI
and Rf-1A single congenic rats. At the first time point,
following two-kidney + L-NAME treatment, Rf-4 single
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Fig. 3. Tail-cuff blood pressure at 6, 12, and 18 weeks in August × Copenhagen Irish (ACI) (), Rf-1A (), Rf-4 (), and Rf-1A+4 (•) rats. (A)
Two-kidney. (B) Two-kidney + L-arginine analogue N-nitro-L-arginine methyl ester (L-NAME)–induced hypertension. (C) Unilateral nephrectomy.
(D) Unilateral nephrectomy + L-NAME–induced hypertension. Values (mm Hg) are given as mean ± SEM; number of rats is given in Table 1.
∗P < 0.05 vs. ACI, Rf-1A, and Rf-4; +P < 0.05 vs. ACI and Rf-1A; ◦P < 0.05 vs. ACI. SBP is systolic blood pressure.
congenic rats had a significantly lower systolic blood pres-
sure compared to ACI and Rf-1A. This difference was not
seen at the second and third evaluations (Fig. 3B). The Rf-
1A+4 double congenics with unilateral nephrectomy +
L-NAME treatment, showed a higher systolic blood pres-
sure at the first and second evaluations compared to ACI
and to Rf-1A single congenics at the second evaluation.
However, at the final evaluation there was no difference
present (Fig. 3D).
Gene-gene and gene-treatment interactions
The results of the 2 × 2 factorial ANOVA analyses
showed the presence of significant gene-gene interac-
tions. While Rf-4 alone showed no effect on UAV when
compared to ACI, combining Rf-4 with Rf-1A always re-
sulted in a further increase in UAV when compared with
Rf-1A single congenics. Furthermore, the magnitude of
these interactions was significant in all four treatments.
However, the greater the hemodynamic stress upon the
kidney, the greater the synergistic effect.
An example is presented in Figure 4, for the UAV
at the second time point, after 12 weeks of treatment.
It is shown that changing the Rf-1 genotype from ho-
mozygous ACI (AA) to homozygous FHH (FF), while
the Rf-4 genotype remains AA, induced an increase in
UAV per 100 g body weight in all treatment groups. In
contrast, changing the Rf-4 genotype from AA to FF,
while the Rf-1 genotype remains AA, showed almost no
change in UAV. Assuming an additive effect on UAV
when both Rf-1 and Rf-4 change from AA to FF, an
expected change in UAV can be calculated. In all four
situations, the observed changes in UAV significantly ex-
ceeded the expected change. The difference, being the
interactive effect between Rf-1 and Rf-4 depended on
the experimental situation, but was significant in all treat-
ment groups. The magnitude was small with two-kidney
(+1.5 mg/day/100 g body weight), intermediate with two-
kidney + L-NAME (+12.5 mg/day/100 g body weight),
and unilateral nephrectomy (+11.7 mg/day/100 g body
weight) and large in the unilateral nephrectomy + L-
NAME situation (30.9 mg/day/100 g body weight).
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Fig. 4. The effects of the Rf-1 and Rf-4 (chromosome 14) genotype and their interaction of Rf-1 and Rf-4 on albuminuria (UAV) after 12 weeks of
treatment. (A)Two-kidney. (B) Two-kidney + L-arginine analogue N-nitro-L-arginine methyl ester (L-NAME)–induced hypertension. (C) Unilateral
nephrectomy. (D) Unilateral nephrectomy + L-NAME–induced hypertension. Abbreviations are: AA, homozygous August × Copenhagen Irish
(ACI); FF, homozygous Fawn-Hooded hypertensive (FHH). Values for UAV (mg/day per 100 g body weight) are mean ± SEM. Statistics are given
in Table 2.
Additional information about the effects of the Rf-1
and Rf-4 QTLs and their interactions on UAV at all three
time points is provided in Table 2. The major finding being
that the magnitude of the interaction between Rf-1 and
Rf-4 not only depended on the type of treatment but also
on the duration of the treatments (i.e., the longer the
treatment the larger the interaction).
Findings at end of experiment
The incidence of focal segmental glomerulosclerosis
(%FSGS), creatinine clearance per 100 g body weight,
and plasma albumin level are summarized in Table 3.
The%FSGS was significantly higher in Rf-1A+4 double
congenic rats compared to ACI, Rf-4 and Rf-1A single
congenic rats, regardless of treatment. Following both
two-kidney + L-NAME and unilateral nephrectomy +
L-NAME, the %FSGS was significantly higher in Rf-1A
single congenics compared to ACI rats. Irrespective of
the treatment, no statistically significant differences in
%FSGS were found between Rf-4 single congenics and
ACI rats.
As with UAV, a significant interactive effect upon
the%FSGS was present between the Rf-1 and Rf-4 QTLs.
The magnitude of the interaction differed per treatment.
It was low (+9 ± 6%) (P = 0.021) for two-kidney, in-
termediate ((+21 ± 10%) P = 0.002) for two-kidney +
L-NAME and for unilateral nephrectomy (+24 ± 10%)
(P < 0.001), and most pronounced for unilateral nephrec-
tomy + L-NAME treatment (+49 ± 12%) (P < 0.001).
In the two-kidney and unilateral nephrectomysitua-
tion, creatinine clearance per 100 g body weight level was
significantly lower in Rf-1A single congenic and Rf-1A+4
double congenic rats compared to Rf-4 single congenics.
Following two-kidney + L-NAME, creatinine clearance
per 100 g body weight was lower in Rf-1A+4 double con-
genics compared to all other strains, while in Rf-1A sin-
gle congenic rats it was lower compared to Rf-4 single
congenic rats. After unilateral nephrectomy + L-NAME
treatment, creatinine clearance per 100 g body weight of
Rf-1A+4 double congenics and Rf-1A single congenics
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Table 2. Effect of the Rf-1 and Rf-4 quantitative trait loci (QTLs) and their interaction on albuminuria (UAV)
2 × 2 factorial 2 × 2 factorial 2 × 2 factorial
6 weeks of ANOVA 12 weeks of ANOVA 18 weeks of ANOVA
treatment P value treatment P value treatment P value
Two-kidney
Rf-4 effect −0.3 ± 0.9 P = 0.476 −0.5 ± 0.4 P = 0.234 −0.3 ± 0.6 P = 0.178
Rf-1 effect +0.6 ± 0.5 P < 0.001 +0.5 ± 0.4 P < 0.001 +0.9 ± 0.7 P < 0.001
Interaction of Rf-1 and Rf-4 +0.8 ± 0.8 P = 0.072 +1.5 ± 0.8 P = 0.009 +1.6 ± 1.3 P = 0.045
Two-kidney + L-NAME
Rf-4 effect −0.8 ± 1.0 P = 0.116 −0.5 ± 0.9 P = 0.002 −0.3 ± 2.1 P < 0.001
Rf-1 effect +1.6 ± 1.3 P < 0.001 +3.4 ± 2.9 P < 0.001 +7.1 ± 6.9 P < 0.001
Interaction of Rf-1 and Rf-4 +3.3 ± 1.4 P < 0.001 +12.5 ± 5.1 P < 0.001 +39.5 ± 10.7 P < 0.001
Unilateral nephrectomy
Rf-4 effect −1.5 ± 1.4 P = 0.155 −2.5 ± 1.7 P = 0.010 −4.5 ± 2.8 P = 0.011
Rf-1 effect +2.2 ± 2.0 P < 0.001 +4.2 ± 3.6 P < 0.001 +7.4 ± 5.2 P < 0.001
Interaction of Rf-1 and Rf-4 +4.8 ± 2.6 P = 0.004 +11.7 ± 4.7 P < 0.001 +15.9 ± 5.2 P < 0.001
Unilateral nephrectomy + L-NAME
Rf-4 effect −1.0 ± 1.4 P = 0.003 −0.9 ± 3.3 P < 0.001 +7.7 ± 13.0 P < 0.001
Rf-1 effect +5.1 ± 2.7 P < 0.001 +15.7 ± 6.9 P < 0.001 +30.9 ± 14.7 P = 0.012
Interaction of Rf-1 and Rf-4 +11.8 ± 6.4 P = 0.005 +30.9 ± 11.3 P < 0.001 +18.2 ± 16.1 P = 0.009
Abbreviations are: ANOVA, analysis of variance; L-NAME, L-arginine analogue N-nitro-L-arginine methyl ester; ACI, August × Copenhagen Irish. For each
treatment and time point the Rf-4 effect (UAVRf−4 – UAVACI), the Rf-1 effect (UAVRf−1A − UAVACI), and the interaction (UAVRf−1A+4 – UAVRf−1A − UAVRf−4 +
UAVACI) were calculated. Data represent change in UAV (mg/day per 100 g body weight) ± SD. Statistical significance of the overall (main) effect of Rf-1 and Rf-4
and their interaction were calculated using 2 × 2 factorial ANOVA.
Table 3. Measurements at end of follow-up
Creatinine clearance Plasma
Number Body weight g FSGS % glomeruli mL/min/100 g body weight albumin g/L
Two-kidney
August × Copenhagen Irish 6 303 ± 4 10 ± 2 0.55 ± 0.05 28.8 ± 0.9
Rf-4 9 317 ± 7 8 ± 1 0.66 ± 0.05 28.9 ± 0.6
Rf-1A 11 326 ± 5 15 ± 2c 0.45 ± 0.03b 28.9 ± 0.5
Rf-1A+4 12 327 ± 5a 22 ± 2d 0.44 ± 0.03b 28.6 ± 0.5
ANOVA P = 0.037 P < 0.001 P < 0.001 P = 0.977
Two-kidney + L-NAME
August × Copenhagen Irish 6 312 ± 8 14 ± 4 0.54 ± 0.02 29.1 ± 0.2
Rf-4 9 309 ± 4 6 ± 1 0.62 ± 0.03 29.3 ± 0.3
Rf-1A 12 326 ± 4 26 ± 2c 0.47 ± 0.02b 27.7 ± 0.5
Rf-1A+4 10 278 ± 6d 39 ± 5d 0.34 ± 0.03d 25.8 ± 0.8d
ANOVA P < 0.001 P < 0.001 P < 0.001 P < 0.001
Unilateral nephrectomy
August × Copenhagen Irish 10 309 ± 6 18 ± 2 0.50 ± 0.03 27.8 ± 0.4
Rf-4 10 298 ± 4 6 ± 2 0.56 ± 0.03 28.2 ± 0.3
Rf-1A 12 324 ± 6c 26 ± 3c 0.46 ± 0.02b 26.3 ± 0.5
Rf-1A+4 12 331 ± 5c 38 ± 5d 0.45 ± 0.02b 25.0 ± 0.4d
ANOVA P < 0.001 P < 0.001 P = 0.014 P < 0.001
Unilateral nephrectomy + L-NAME
August × Copenhagen Irish 9 301 ± 10 20 ± 3 0.52 ± 0.03 27.2 ± 0.6
Rf-4 10 283 ± 6 16 ± 6 0.51 ± 0.02 27.2 ± 0.8
Rf-1A 12 320 ± 5c 42 ± 3c 0.37 ± 0.02c 23.2 ± 1.0c
Rf-1A+4 14 258 ± 10c 69 ± 3d 0.34 ± 0.04c 23.5 ± 0.7c
ANOVA P < 0.001 P < 0.001 P < 0.001 P < 0.001
Abbreviations are FSGS, focal segmental glomerulosclerosis, ANOVA, analysis of variance; L-NAME, L-arginine analogue N-nitro-L-arginine methyl ester. Values
are given as mean ± SEM.
aP < 0.05 vs. August × Copenhagen Irish; bP < 0.05 vs. Rf-4; cP < 0.05 vs. August × Copenhagen Irish and Rf-4; dP < 0.05 vs. August × Copenhagen Irish, Rf-4, and Rf-1A.
was lower than that of Rf-4 single congenics and ACI
rats. At the end of the follow-up, plasma albumin level
was significantly decreased in Rf-1A+4 double congenic
rats compared to all other strains after two-kidney + L-
NAME or unilateral nephrectomy treatment, and com-
pared to ACI and Rf-4 single congenics after unilateral
nephrectomy + L-NAME treatment. Following unilat-
eral nephrectomy + L-NAME treatment, Rf-1A single
congenics also showed a lower plasma albumin level in
comparison to ACI and Rf-4 single congenic rats.
Assessment of RBF autoregulation
No differences were found in the absolute values of the
RBF at 100 mm Hg between ACI, Rf-1A, Rf-4, and Rf-
1A+4 rats. Despite the relatively large variations within
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Fig. 5. Renal blood flow (RBF) autoregulation curves in two-kidney
August × Copenhagen Irish (ACI) () (N = 15), Rf-1A () (N = 12),
Rf-4 () (N = 15), and Rf-1A+4 (•) (N = 12) rats. Values [as%RBF
at renal perfusion pressure (RPP) of 100 mm Hg] are given as means ±
SEM (error bars). ∗P < 0.05 vs. ACI and Rf-4.
each strain, a significantly higher RBF at a RPP of 150 mm
Hg was present in the Rf-1A and Rf-1A+4 rats in com-
parison with ACI rats (data not shown). After normaliz-
ing the RBF, more significant differences were revealed
(Fig. 5). From 130 to 150 mm Hg, mean%RBF values
were significantly higher in the Rf-1A single congenics
compared to ACI rats. At 150 mm Hg, mean%RBF value
of Rf-1A+4 double congenics was significantly higher
compared to ACI rats. This points to an impairment of
the RBF autoregulation in Rf-1A and Rf-1A+4 rats. Over
the pressure range 100 to 150 mm Hg, the RAIs were in
the order of 0.2 to 0.3 in ACI as well as in Rf-4 single
congenics, indicating a normal renal autoregulation in
these strains. In contrast, RAI values were significantly
increased to levels of about 0.4 to 0.7 in Rf-1A single and
Rf-1A+4 double congenic rats, indicating an impaired re-
nal autoregulation.
No marked renal damage was present in the rats used
for the autoregulation experiment. In all four strains, the
average UAV level was about 2 to 4 mg/day/100 g body
weight, while the percentage of injured glomeruli was in
the order of 2% to 6%.
DISCUSSION
The major finding of our present study is the presence
of a powerful synergistic interaction between the Rf-1 and
Rf-4 QTLs that is markedly enhancing the susceptibility
to renal damage as measured by the levels of UAV during
and the%FSGS at the end of the follow-up. The magni-
tude of the interactive effect differs between the various
treatments, and appears to depend on the intensity and
the duration of the exposure to the various stressors. The
largest effect is observed when a reduction in renal mass
by unilateral nephrectomy is combined with L-NAME–
induced hypertension. A moderate effect is noted follow-
ing unilateral nephrectomy or L-NAME–induced hyper-
tension. Even in the two-kidney situation there appears
to be a small synergistic interaction.
The interpretation of the present finding of an interac-
tion between the Rf-1 and Rf-4 QTL is complicated by
the presence of a second part of the FHH chromosome 14
introgressed in the Rf-1A+4 double congenic rats. How-
ever, this extra part located between 36.4 and 74.0 Mb
is way off the 95% CI of the Rf-4 QTL (i.e., between
5 and 20 Mb). In theory, a gene or genes in this addi-
tional part could account for the increased susceptibility
of the double congenic strain. Preliminary data, obtained
by Jacob and Lutz (Lutz et al, manuscript in preparation),
exclude a role of the distal part of chromosome 14. In or-
der to narrow down the interval of the Rf-4 QTL, a panel
of subcongenic strains was generated from the Rf-1A+4
and Rf-1A strains tested in the present experiments. One
of the subcongenic strains (Rf1A+4 by) was identical to
the Rf-1A+4 with regard to the distal part of chromo-
some 14, but the FHH genotype between the markers
D14Mit11 (4.9 Mb) and D14Mit2 (19.1 Mb) was replaced
by ACI. In these strains susceptibility to renal damage
was compared with Rf-1A single congenics. Following
8 weeks of unilateral nephrectomy and L-NAME treat-
ment UAV corrected for body weight in the Rf-1A+4 by
subcongenic (34 ± 6 mg/day) (N = 6) (mean ± SEM) was
significantly less that that of Rf-1A+4 double congenics
(98 ± 10 mg/day) (N = 20), but not different from that of
Rf-1A single congenics (31 ± 4 mg/day) (N = 6). These
findings indicate that the gene(s) responsible for the in-
teraction between the Rf-1 and Rf-4 QTLs is located on
chromosome 14 in the 4.9 and 19.1 Mb interval. Future
studies aim to further reduce the size of the Rf-4 interval
and positionally clone the Rf-4 gene(s).
Nature of the interaction
In recent years, there is an increasing awareness that
genetic and environmental factors play an important role
in common complex diseases in humans, such as diabetes,
hypertension, and mental disorders [32–34]. Double con-
genic rat strains have been studied to establish inter-
actions between blood pressure QTLs [24, 25]. To our
knowledge, the present findings are the first to directly
show a QTL interaction increasing susceptibility to renal
damage. Such an interaction between the Rf-1 and Rf-4
QTLs was predicted in an F2 population from a cross of
FHH and ACI rats subjected to unilateral nephrectomy
[21]. The synergistic interaction is extremely powerful in
this protective genomic background, particularly in the
presence of kidney stressors. This observation could be
important in understanding the variability found in the
human situation.
Gene-gene interactions may have different phenotypic
implications [35]. For example, the interaction could be
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additive, where the combined effect of Rf-1 and Rf-4 in
the double congenic strain would roughly be equal to the
sum of the effects of Rf-1 and Rf-4 on the phenotype.
Irrespective of treatment the effect of Rf-4 on UPV and
UAV was only marginal, and therefore additivity can be
excluded for UPV and UAV, but not for FSGS. The UPV
and UAV results clearly show that the gene-gene inter-
action has a powerful synergistic effect, consistent with
epistasis for complex traits [36]. Our findings fit this con-
cept. The effects of changing the genotype of Rf-1 and
Rf-4 from homozygous ACI to homozygous FHH has a
powerful and significant effect on the pathophysiologic
parameters of renal damage. In addition, the complexity
of the gene-gene interaction is further distended by the
fact that the effects on renal damage of changing the Rf-1
and Rf-4 genotypes also depends on the severity of the
(hemodynamic) strain put upon the kidney and the length
of the exposure to the harmful stimuli. The renal damage
parameters (UAV and FGS) are distant traits (i.e., not
likely to be directly related to a gene defect). With the
generation of the Rf-1A+4 double congenics we have
constructed a relatively simple two-loci model that re-
sults in an increased susceptibility to renal damage. One
effect of Rf-1 appears to be an impairment of the renal
autoregulation, which might result in an increased PGC
when faced with systemic hypertension and/or reduced
renal mass. The effect of Rf-4 appears to be on a different
level and only becomes detectable presence two copies
of the Rf-1 QTL from FHH. We can only speculate about
possible mechanism(s) of action of Rf-4. It is conceivable
that Rf-4 as well as other Rf -QTLs play a role in pro-
tecting the integrity of the glomerular filtration barrier
when exposed to an increased PGC. Although this limits
the number of possible candidates, it still leaves a wide
range of molecular pathways important in the biology of
the podocyte and the glomerular barrier [37–40].
Next to five QTLs in FHH, numerous QTLs influ-
encing parameters of renal damage have been detected
in other strains [41–46]. The Rat Genome Database
(http://rgd.mcw.edu) has collected over 90 QTLs associ-
ated with renal damage or renal function components,
some of them overlapping with the five Rf -QTLs. As
far as renal damage is concerned, it looks as if 15 to 20
different loci might be involved in the various rat mod-
els [1]. Should a similar number of QTLs also play a
role in humans, the number of possible interacting gene
combinations that can be derived from these loci be-
comes tremendous. Inbred rat models remain relevant
for gene identification and gene interaction, as the num-
ber of gene combinations per strain is relatively small.
With the detection of an interaction between Rf-1 and
Rf-4, we continue to investigate the interaction between
Rf-1 and the three other Rf-QTLs. The ultimate goal,
of course, is to identify the genes in the various Rf -
QTLs, as recently accomplished for Rf-2 [47], and es-
tablish how they affect susceptibility to renal damage
and how they interact [48]. Subsequently, these genes
and gene-gene interactions can be tested in humans.
With the recent completion of the sequencing of the
rat genome [49] it has become feasible to make a rat,
mouse, and human genome comparison [50]. Analysis
of the genes present in the various Rf-regions with the
Ensembl Genome Browser (http://www.ensembl.org) in-
dicated that the 25 Mb Rf-1 interval on rat chromosome
1 contains about 200 known and predicted genes with
homologies in both mouse and human. The 25 Mb Rf-4
interval on rat chromosome 14 contains about 130 known
and predicted genes. Currently, 15% to 25% of the genes
are predicted, novel, genes without a description of the
gene product, while the description of others is vague.
Eventually, shortening the congenic region will further
decrease the number of candidate genes.
CONCLUSION
The present studies show that there is an interaction be-
tween the Rf-1 and Rf-4 QTL, which is markedly enhanc-
ing the susceptibility to renal damage in ACI genomic
background that is ordinarily protective for proteinuria.
It appears that the Rf-1 QTL of the FHH rat contains
one or more genes directly influencing renal susceptibil-
ity, possibly by impairing the efficacy of renal autoregu-
lation. The Rf-4 QTL also contains one or more genes
that influence renal susceptibility. However, the effect of
the Rf-4 QTL can only be observed in the homozygous
presence of the Rf-1 QTL from the FHH rat.
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